Dysferlin is expressed in human placenta but does not associate with caveolin

Biology of Reproduction

Volumn 77, Issue 3, 2007, Pages 533-542

  Vandré, Dale D ^a   Ackerman IV, William E ^a   Kniss, Douglas A ^a   Tewari, Arun K ^a   Mori, Miki ^b   Takizawa, Toshihiro ^b   Robinson, John M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Caveolin; Dysferlin; Placenta; Syncytiotrophoblast; Trophoblast

Indexed keywords

CAVEOLIN; DYSFERLIN;

APICAL MEMBRANE; ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; SYNCYTIUM; TROPHOBLAST;

CAVEOLINS; CELL MEMBRANE; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MUSCLE PROTEINS; PLACENTA; PREGNANCY; PROTEOMICS;

EID: 34548221348     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.107.062190     Document Type: Article

References (48)

1. Benirschke K, Kaufmann P. Pathology of the Human Placenta, 4th ed. New York: Springer-Verlag; 2000.
2. Stulc J. Placental transfer of inorganic ions and water. Physiol Rev 1997; 77:805-836.
3. Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine 2002; 19:13-22.
4. Regnault TR, Friedman JE, Wilkening RB, Anthony RV, Hay WW Jr. Fetoplacental transport and utilization of amino acids in IUGR - a review. Placenta 2005; 26(suppl A):S52-S62.
5. Woollett LA. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr 2005; 82:1155-1161.
6. Fowden AL, Ward JW, Wooding FP, Forhead AJ, Constancia M. Programming placental nutrient transport capacity. J Physiol 2006; 572:5-15.
7. Jansson T, Powell TL. IFPA 2005 Award in Placentology Lecture. Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? - a review. Placenta 2006; 27(suppl A):S91-S97.
8. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, Bohlega S, Culper EJ, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998; 20:31-36.
9. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, Richard I, Marchand S, Bourg N, Argov Z, Sadeh M, Mahjneh I, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998; 20:37-42.
10. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003; 423:168-172.
11. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH Jr. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003; 278:50466-50473.
12. Hernandez-Deviez DJ, Martin S, Laval SH, Lo HP, Cooper ST, North KN, Bushby K, Parton RG. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hum Mol Genet 2006; 15:129-142.
13. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 1997; 272:29337-29346.
14. Way M, Parton RG. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 1996; 378:108-112.
15. McNally EM, de Sa Moreira E, Duggan DJ, Bonnemann CG, Lisanti MP, Lidov HG, Vainzof M, Passos-Bueno MR, Hoffman EP, Zatz M, Kunkel LM. Caveolin-3 in muscular dystrophy. Hum Mol Genet 1998; 7:871-877.
16. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998; 18:365-368.
17. Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V, Torbergsen T, Lee YA, Nothen MM, Wienker TF, Malin JP, Propping P, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001; 28:218-219.
18. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, Nonaka I, Arahata K, Brown RH Jr. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 2001; 10:1761-1766.
19. Galbiati F, Volonte D, Minetti C, Chu JB, Lisanti MP. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. J Biol Chem 1999; 274:25632-25641.
20. Lyden TW, Anderson CL, Robinson JM. The endothelium but not the syncytiotrophoblast of human placenta expresses caveolae. Placenta 2002; 23:640-652.
21. Takizawa T, Anderson CL, Robinson JM. A new method to enhance contrast of ultrathin cryosections for immunoelectron microscopy. J Histochem Cytochem 2003; 51:31-39.
22. Takizawa T, Anderson CL, Robinson JM. A novel Fc gamma R-defined, IgG-containing organelle in placental endothelium. J Immunol 2005; 175:2331-2339.
23. Bush WS, Ihrke G, Robinson JM, Kenworthy AK. Antibody-specific detection of caveolin-1 in subapical compartments of MDCK cells. Histochem Cell Biol 2006; 126:27-34.
24. Takizawa T, Robinson JM. Correlative microscopy of ultrathin cryosections in placental research. Methods Mol Med 2006; 121:351-369.
25. Chaney LK, Jacobson BS. Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. J Biol Chem 1983; 258:10062-10072.
26. Jacobson BS, Stolz DE, Schnitzer JE. Cells: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1998:1-35.
27. Fujiki Y, Hubbard AL, Fowler S, Lazarow PB. Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J Cell Biol 1982; 93:97-102.
28. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF III. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986; 118:1567-1582.
29. Humphrey RG, Smith SD, Pang L, Sadovsky Y, Nelson DM. Fibrin enhances differentiation, but not apoptosis, and limits hypoxic injury of cultured term human trophoblasts. Placenta 2005; 26:491-497.
30. Roh CR, Budhraja V, Kim HS, Nelson DM, Sadovsky Y. Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. Placenta 2005; 26:319-328.
31. Mishima T, Kurasawa G, Ishikawa G, Mori M, Kawahigashi Y, Ishikawa T, Luo SS, Takizawa T, Goto T, Matsubara S, Takeshita T, Robinson JM, Takizawa T. Endothelial expression of Fc gamma receptor IIb in the full-term human placenta. Placenta 2007; 28:170-174.
32. Ding M, Robinson JM, Behrens BC, Vandre DD. The microtubule cytoskeleton in human phagocytic leukocytes is a highly dynamic structure. Eur J Cell Biol 1995; 66:234-245.
33. Robinson JM, Vandre DD. Antigen retrieval in cells and tissues: enhancement with sodium dodecyl sulfate. Histochem Cell Biol 2001; 116:119-130.
34. Mori M, Ishikawa G, Takeshita T, Goto T, Robinson JM, Takizawa T. Ultrahigh-resolution immunofluorescence microscopy using ultrathin cryosections: subcellular distribution of caveolin-1 alpha and CD31 in human placental endothelial cells. J Electron Microsc (Tokyo) 2006; 55:107-112.
35. Kao LC, Caltabiano S, Wu S, Strauss JF III, Kliman HJ. The human villous cytotrophoblast: interactions with extracellular matrix proteins, endocrine function, and cytoplasmic differentiation in the absence of syncytium formation. Dev Biol 1988; 130:693-702.
36. Lambot N, Lybaert P, Boom A, ogne-Desnoeck J, Vanbellinghen AM, Graff G, Lebrun P, Meuris S. Evidence for a clathrin-mediated recycling of albumin in human term placenta. Biol Reprod 2006; 75:90-97.
37. Linton EA, Rodriguez-Linares B, Rashid-Doubell F, Ferguson DJP, Redman CWG. Caveolae and caveolin-1 in human term villous trophoblast. Placenta 2003; 24:745-757.
38. Byrne S, Ahenkorah J, Hottor B, Lockwood C, Oclleford CD. Immunoelectron microscopic localization of caveolin 1 in human placenta. Immunobiology 2007; 212:39-46.
39. Newton AC. Protein kinase C. Seeing two domains. Curr Biol 1995; 5:973-976.
40. Bansal D, Campbell KP. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 2004; 14:206-213.
41. Reddy A, Caler EV, Andrews NW. Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell 2001; 106:157-169.
42. Huppertz B, Tews DS, Kaufmann P. Apoptosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int Rev Cytol 2001; 205:215-253.
43. Huppertz B, Frank HG, Kingdom JC, Reister F, Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998; 110:495-508.
44. Martin BJ, Spicer SS. Ultrastructural features of cellular maturation and aging in human trophoblast. J Ultrastruct Res 1973; 43:133-149.
45. Jones CJ, Fox H. Syncytial knots and intervillous bridges in the human placenta: an ultrastructural study. J Anat 1977; 124:275-286.
46. Abumaree MH, Stone PR, Chamley LW. An in vitro model of human placental trophoblast deportation/shedding. Mol Hum Reprod 2006; 12:687-694.
47. Jimenez V, Henriquez M, Llanos P, Riquelme G. Isolation and purification of human placental plasma membranes from normal and pre-eclamptic pregnancies. A comparative study. Placenta 2004; 25:422-437.
48. Davis DB, Doherty KR, Delmonte AJ, McNally EM. Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J Biol Chem 2002; 277:22883-22888.